Experimental Treatment of Ebola Virus Disease with Brincidofovir
Jake Dunning(University of Oxford), Jennifer Grove(University of Oxford), Raul Pardinaz-Solis(University of Oxford), Annick Antierens(Médecins Sans Frontières), Piero Olliaro(University of Oxford), Peter Horby, Trudie Lang(Angkor Hospital for Children), Gail Carson, Stephen B. Kennedy(University of Liberia), Rupa Kanapathipillai, Rebecca Howell‐Jones(Centre international de recherche sur le cancer), Iza Ciglenečki(Médecins Sans Frontières), John Whitehead(Lancaster City Council), J. T. Scott(MRC University of Glasgow Centre for Virus Research), L Castle
Cited by 103
Related Papers
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
|JAMA|2020|2.4k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k
Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication
|International Journal of Cancer|2010|1.1k